This topic contains a solution. Click here to go to the answer

Author Question: Of the following, which does the CACREP Professional Identity section not mandate for programs? ... (Read 87 times)

go.lag

  • Hero Member
  • *****
  • Posts: 667
Of the following, which does the CACREP Professional Identity section not mandate for programs?
 
  A. Mission statement
  B. Common-core curricular experiences
  C. Program objectives
  D. All of the answers are mandated.

Question 2

A central role of members during the transition stage is to recognize and deal with the many forms of defensiveness. These tasks include the following EXCEPT
 
  a. recognizing and expressing the range of feelings and thoughts.
 b. moving from dependence to independence.
 c. taking increased responsibility for what they are doing in the group.
 d. not being willing to deal with reactions toward what is occurring in the group.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

tuate

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

D

Answer to Question 2

d




go.lag

  • Member
  • Posts: 667
Reply 2 on: Jul 30, 2018
Great answer, keep it coming :)


kthug

  • Member
  • Posts: 332
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Side effects from substance abuse include nausea, dehydration, reduced productivitiy, and dependence. Though these effects usually worsen over time, the constant need for the substance often overcomes rational thinking.

Did you know?

Addicts to opiates often avoid treatment because they are afraid of withdrawal. Though unpleasant, with proper management, withdrawal is rarely fatal and passes relatively quickly.

Did you know?

Stroke kills people from all ethnic backgrounds, but the people at highest risk for fatal strokes are: black men, black women, Asian men, white men, and white women.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Your heart beats over 36 million times a year.

For a complete list of videos, visit our video library